-
-
-
Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched study.
-
Investigation of difference between chronological and vascular age in persons with Multiple Sclerosis.
-
Pregnancy and Infant Outcomes in Women With Multiple Sclerosis Treated With Ocrelizumab
- Safety tests in the clinical management of MS
- Advancing MS Education and Care
- Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched study.
- Investigation of difference between chronological and vascular age in persons with Multiple Sclerosis.
- Pregnancy and Infant Outcomes in Women With Multiple Sclerosis Treated With Ocrelizumab
All Learning Material
- All learning material
- COVID-19
- Clinical cases
- Data
- Diagnosis
- Epidemiology
- Evolution of Disease
- Immunology
- Innovation
- Lifestyle
- MRI
- Management
- Microglia
- NMO
- OCT
- Pathology
- Patient Care
- Pediatric
- Precision medicine
- Pregnancy
- Prognosis
- Progressive MS
- Quality of Life
- Rehabilitation
- Safety
- Tolerability & Adherence
- Treatments
- Virtual care
- x – EACCME
- x – Presentation (PPT)
- x – Publications (Journal)
- x – Recorded Webinars
- x – Report
- x – Video Interview
- x – e-learning